Effect of Octreotide on Apoptosis-related Proteins in Rat Kupffer Cells: A Possible Anti-tumour Mechanism

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 833-841

  Xidakis, Costas ^a   Kolios, George ^a   Valatas, Vassilis ^a   Notas, George ^a   Mouzas, Ioannis ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Apoptosis; Kupffer cells; LPS; Octreotide

Indexed keywords

CASPASE 3; LIPOPOLYSACCHARIDE; MESSENGER RNA; OCTREOTIDE; PROTEIN; PROTEIN BAX; PROTEIN BCL X;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; KUPFFER CELL; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CASPASES; GENE EXPRESSION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MALE; OCTREOTIDE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 2442443153     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Knolle PA and Gerken G: Local control of the immune response in the liver. Immunol Rev 174: 21-34, 2000.
2. Naito M, Hasegawa G and Takahashi K: Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 39: 350-364, 1997.
3. Bautista AP: Acute alcohol intoxication and endotoxemia desensitize HIV-1 gp120-induced CC-chemokine production by Kupffer cells. Life Sci 68: 1939-1949, 2001.
4. Gregory SH and Wing EL: Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 72: 239-248, 2002.
5. Su GL: Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283: G256-G265, 2002.
6. Fischer R, Cariers A, Reinehr R and Haussinger D: Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 123: 845-861, 2002.
7. Neuman MG: Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci 38: 109-166, 2001.
8. Muschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R and Haussinger D: Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 116: 666-677, 1999.
9. Sun Z, Wada T, Maemura K, Uchikura K, Hoshino S, Diehl AM and Klein AS: Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 9: 489-497, 2003.
10. Cuesta N, Salkowski CA, Thomas KE and Vogel SN: Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J Immunol 170: 5739-5747, 2003.
11. Reichlin S: Somatostatin. N Engl J Med 309: 1495-1501, 1983.
12. Brazeau P: Somatostatin: a peptide with unexpected physiologic activities. Am J Med 81: 8-13, 1986.
13. ten Bokum AM, Hofland LJ and van Hagen PM: Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 11: 161-176, 2000.
14. Lamberts SW: The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9: 417-436, 1988.
15. Kvols LK, Buck M, Moertel CG, Schutt AJ, Rubin J, O'Connell MJ and Hahn RG: Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 107: 162-168, 1987.
16. Jia WD, Xu GL, Xu RN, Sun HC, Wang L, Yu JH, Wang J, Li JS, Zhai ZM and Xue Q: Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol 129: 327-34, 2003.
17. Florio T, Morini M, Villa V, Arena S, Corsaro A, Thellung S, Culler MD, Pfeffer U, Noonan DM, Schettini G and Albini A: Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology 144: 1574-1584, 2003.
18. Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J and Manousos ON: Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 42: 442-447, 1998.
19. Samonakis DN, Moschandreas J, Arnaoutis T, Skordilis P, Leontidis C, Vafiades I and Kouroumalis E: Treatment of hepatocellular carcinoma with long acting somatostatin analogues. Oncol Rep 9: 903-907, 2002.
20. Davies N, Yates J, Kynaston H, Taylor BA and Jenkins SA: Effects of octreotide on liver regeneration and tumour growth in the regenerating liver. J Gastroenterol Hepatol 12: 47-53, 1997.
21. Valatas V, Xidakis C, Roumpaki H, Kolios G and Kouroumalis E: Isolation of rat Kupffer cells; a combined methodology for highly purified primary cultures. Cell Biol Int 27: 67-73, 2002.
22. Knook DL and Sleyster EC: Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 99: 444-449, 1976.
23. Kolios G, Valatas V, Psilopoulos D, Petraki K and Kouroumalis E: Depletion of non specific esterase activity in the colonic mucosa of patients with ulcerative colitis. Eur J Clin Invest 32: 265-273, 2002.
24. Jordan NJ, Kolios G, Abbot SE, Sinai MA, Thompson DA, Petraki K and Westwick J: Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest 104: 1061-1069, 1999.
25. Davies N, Kynaston H, Yates J, Nott DM, Jenkins SA and Taylor BA: Reticuloendothelial stimulation: levamisole compared. Dis Colon Rectum 36: 1054-1058, 1993.
26. Frizelle FA: Octreotide inhibits the growth and development of three types of experimental liver metastasis. Br J Surg 82: 1577-1995.
27. Davies N, Kynaston H, Yates J, Nott DM, Nash J, Taylor BA and Jenkins SA: Octreotide inhibits the growth and development of three types of experimental liver metastases. Br J Surg 82: 840-843, 1995.
28. Nakaizumi A, Uehara H, Baba M, Iishi H and Tatsuta M: Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Carcinogenesis 14: 2601-2604, 1993.
29. Schindel DT and Grosfeld JL: Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide. J Pediatr Surg 32: 995-997, 1997.
30. Imam H, Eriksson B, Lukinius A, Janson ET, Lindgren PG, Wilander E and Oberg K: Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncol 36: 607-614, 1997.
31. Davies N, Kynaston H, Yates J, Taylor BA and Jenkins SA: Octreotide, the reticuloendothelial system, and experimental liver tumour. Gut 36: 610-614, 1995.